These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 28411262)

  • 1. Aspirin's Benefits Were Previously Underestimated and Are Primarily Accrued in the Acute Setting.
    Amarenco P; Kim AS
    Stroke; 2017 May; 48(5):1438-1440. PubMed ID: 28411262
    [No Abstract]   [Full Text] [Related]  

  • 2. Dual Antiplatelet Therapy for Minor Stroke and High-Risk Transient Ischemic Attack.
    Liu L; Dowlatshahi D
    Stroke; 2018 Sep; 49(9):2278-2279. PubMed ID: 30355000
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevalence of ex vivo high on-treatment platelet reactivity on antiplatelet therapy after transient ischemic attack or ischemic stroke on the PFA-100(®) and VerifyNow(®).
    Kinsella JA; Tobin WO; Cox D; Coughlan T; Collins R; O'Neill D; Murphy RP; McCabe DJ
    J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):e84-92. PubMed ID: 22981273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ticagrelor versus Aspirin in Acute Stroke or Transient Ischemic Attack.
    Johnston SC; Amarenco P
    N Engl J Med; 2016 Oct; 375(14):1395. PubMed ID: 27705253
    [No Abstract]   [Full Text] [Related]  

  • 5. Ticagrelor versus Aspirin in Acute Stroke or Transient Ischemic Attack.
    Landman GW; Kleefstra N
    N Engl J Med; 2016 Oct; 375(14):1394. PubMed ID: 27705254
    [No Abstract]   [Full Text] [Related]  

  • 6. Ticagrelor versus Aspirin in Acute Stroke or Transient Ischemic Attack.
    Čulić V
    N Engl J Med; 2016 Oct; 375(14):1394-1395. PubMed ID: 27705255
    [No Abstract]   [Full Text] [Related]  

  • 7. Dual antiplatelet therapy with clopidogrel and aspirin for secondary stroke prevention.
    Wang Y; Chen W; Wang Y
    Curr Cardiol Rep; 2015 Oct; 17(10):89. PubMed ID: 26294261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New insights in antiplatelet therapy for patients with ischemic stroke.
    Chaturvedi S; Bhattacharya P
    Neurologist; 2011 Sep; 17(5):255-62. PubMed ID: 21881467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The benefits of aspirin in early secondary stroke prevention.
    Hankey GJ
    Lancet; 2016 Jul; 388(10042):312-314. PubMed ID: 27209144
    [No Abstract]   [Full Text] [Related]  

  • 10. Enteric-coated aspirin versus other antiplatelet drugs in acute non-cardioembolic ischemic stroke: post-marketing study in Japan.
    Takahashi S; Mizuno O; Sakaguchi T; Yamada T; Inuyama L
    Adv Ther; 2014 Jan; 31(1):118-29. PubMed ID: 24385407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrent Ischemic Stroke: Strategies for Prevention.
    Oza R; Rundell K; Garcellano M
    Am Fam Physician; 2017 Oct; 96(7):436-440. PubMed ID: 29094912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in usage of alternative antiplatelet therapy after stroke and transient ischemic attack.
    Hills NK; Johnston SC
    Stroke; 2008 Apr; 39(4):1228-32. PubMed ID: 18323509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiplatelet Therapy in Ischemic Stroke and Transient Ischemic Attack.
    Hackam DG; Spence JD
    Stroke; 2019 Mar; 50(3):773-778. PubMed ID: 30626286
    [No Abstract]   [Full Text] [Related]  

  • 14. Ticagrelor versus Aspirin in Acute Stroke or Transient Ischemic Attack.
    Johnston SC; Amarenco P; Albers GW; Denison H; Easton JD; Evans SR; Held P; Jonasson J; Minematsu K; Molina CA; Wang Y; Wong KS;
    N Engl J Med; 2016 Jul; 375(1):35-43. PubMed ID: 27160892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of aspirin and dipyridamole in the treatment of acute ischaemic stroke/transient ischaemic attack: an audit-based discussion.
    Khalil S; Mohanaruban K; Haq S
    Clin Med (Lond); 2009 Apr; 9(2):196-7. PubMed ID: 19437733
    [No Abstract]   [Full Text] [Related]  

  • 16. Rationale and design of a randomized, double-blind, parallel-group study of terutroban 30 mg/day versus aspirin 100 mg/day in stroke patients: the prevention of cerebrovascular and cardiovascular events of ischemic origin with terutroban in patients with a history of ischemic stroke or transient ischemic attack (PERFORM) study.
    Bousser MG; Amarenco P; Chamorro A; Fisher M; Ford I; Fox K; Hennerici MG; Mattle HP; Rothwell PM;
    Cerebrovasc Dis; 2009; 27(5):509-18. PubMed ID: 19372653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of dipyridamole in patients with recent stroke or TIA.
    Bernstein RA
    Am Fam Physician; 2005 Aug; 72(3):382, 384; author reply 384. PubMed ID: 16100852
    [No Abstract]   [Full Text] [Related]  

  • 18. Secondary stroke prevention with antiplatelet therapy with emphasis on the cardiac patient: a neurologist's view.
    Gebel JM
    J Am Coll Cardiol; 2005 Sep; 46(5):752-5. PubMed ID: 16139120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiplatelet therapy with aspirin in acute ischaemic stroke.
    Sandercock P
    Thromb Haemost; 1997 Jul; 78(1):180-2. PubMed ID: 9198149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current guidelines on antiplatelet agents for secondary prevention of noncardiogenic stroke: an evidence-based review.
    Simmons BB; Yeo A; Fung K; ;
    Postgrad Med; 2010 Mar; 122(2):49-53. PubMed ID: 20203455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.